Literature DB >> 32533667

Hospital Pharmacist experience in the Intensive Care Unit: Plan COVID.

Mario García-Gil1, Carlos Velayos-Amo2.   

Abstract

The Intensive Care Unit (ICU) of the University Hospital of Fuenlabrada was  forced to critically increase its capacity in the COVID-19 pandemic. The objective of this work is to describe the activities promoted by the pharmacist in the care  of the critically ill patient in this context. A new organizational structure was  designed, analyzing the tasks necessary to make the processes profitable. Two  pharmacists joined the critical patient care to help the pharmacist who was  already integrated in the ICU team. The development of the operational  structure was carried out on three levels. The healthcare activity highlights the  daily participation of pharmacists in the two clinical sessions in which the ICU  teams evaluated all cases and made decisions. This in turn facilitated the  pharmaceutical validation that was carried out in the critical units themselves. In addition, one of the pharmacists created the Immuno-COVID Committee, in  which they participated together with different specialists for therapeutic  decision-making in the most complex cases. On the other hand, the availability  of human and material resources allowed the implantation of centralized  elaboration in the Pharmacy Service of many intravenous mixtures, including  antibiotics elastomers Pumps for continuous infusion, and non-sterile  elaborations. In logistics management, in addition to the acquisition of COVID- 19 therapies, the reconciliation with nursing activity stands out. The physical presence of the pharmacist favored the detection of needs, the  availability in time of medications in the unit, including sterile and non-sterile  preparations, and coordination with the central pharmacy. In knowledge  management, the participation of the pharmacist in the working group for the  development of the hospital management protocol COVID-19 stands out. The  daily presence in the unit and the joint work with the entire multidisciplinary team demonstrate the value that the pharmacist can bring. In addition to  efficient resource management, support for clinical decision-making and  improvement actions, it provides the climate of inter-professional trust necessary to respond to the complexity of the critical patient and promote joint  projects. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32533667     DOI: 10.7399/fh.11510

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  5 in total

1.  The role of the critical care pharmacist during the COVID-19 pandemic.

Authors:  J Lemtiri; E Matusik; E Cousein; F Lambiotte; N Elbeki
Journal:  Ann Pharm Fr       Date:  2020-10-07

2.  [Contribution of a hospital pharmacy team to critical care of patients infected with SARS-CoV-2].

Authors:  C Besson; S Chareyre; N Kirouani; S Jean-Jean; C Bretagnolle; A Henry; G Leboucher; B Charpiat
Journal:  Ann Pharm Fr       Date:  2021-01-29

3.  Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care units.

Authors:  Claire Chapuis; Rémy Collomp; Laura Albaladejo; Hugo Terrisse; Stéphane Honoré; Jean-Luc Bosson; Pierrick Bedouch; Pierre Albaladejo
Journal:  J Pharm Policy Pract       Date:  2022-04-01

Review 4.  Strengthening the ICUs' human resource-related responses to Covid-19: A rapid review of the experience during the first year of public health emergency.

Authors:  Aizhan Tursunbayeva; Stefano Di Lauro
Journal:  Int J Health Plann Manage       Date:  2022-09-27

Review 5.  COVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists' Roles and Services as a Response to the COVID-19 Pandemic.

Authors:  Kaitlyn E Watson; Theresa J Schindel; Marina E Barsoum; Janice Y Kung
Journal:  Pharmacy (Basel)       Date:  2021-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.